|
|
Volumn 18, Issue 2, 2000, Pages 495-510
|
|
The future of stroke treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;
ABCIXIMAB;
ACETYLSALICYLIC ACID;
AK 275;
AK 295;
ALTEPLASE;
AMPA RECEPTOR;
ANCROD;
ANTICOAGULANT AGENT;
ANTIINFLAMMATORY AGENT;
ANTITHROMBOCYTIC AGENT;
CALCIUM;
CALCIUM ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
CALPASTATIN;
CASPASE;
DIZOCILPINE;
EBSELEN;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
GAVESTINEL;
GLUTAMATE RECEPTOR;
GROWTH FACTOR;
HEPARIN;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NIMODIPINE;
SCAVENGER;
THROMBOXANE A2 RECEPTOR BLOCKING AGENT;
TIRILAZAD;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;
BLOOD CLOT LYSIS;
CALCIUM TRANSPORT;
CLINICAL TRIAL;
CRANIECTOMY;
ENDOTHELIUM;
HUMAN;
INDUCED HYPOTHERMIA;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS INHIBITION;
REPERFUSION INJURY;
REVIEW;
STROKE;
TRANSPLANTATION;
|
|
EID: 0034050689
PISSN: 07338619
EISSN: None
Source Type: Journal
DOI: 10.1016/S0733-8619(05)70204-8 Document Type: Article |
|
Times cited : (28)
|
|
References (94)
|
